Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 3
1980 2
1983 2
1985 1
1986 1
1987 1
1988 1
1991 2
1992 1
1993 1
1994 1
1995 2
1996 2
1997 2
1998 1
1999 1
2000 3
2001 1
2002 1
2004 1
2005 3
2006 4
2007 5
2008 3
2009 5
2010 3
2011 5
2012 5
2013 7
2014 6
2015 15
2016 5
2017 10
2018 13
2019 15
2020 16
2021 12
2022 24
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, López-Jiménez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, Gaidano G, Lee JJ, Abhyankar S, Solano C, Perez de Oteyza J, Satlin MJ, Schwartz S, Campins M, Rocci A, Vallejo Llamas C, Lee DG, Tan SM, Johnston AM, Grigg A, Boeckh MJ, Campora L, Lopez-Fauqued M, Heineman TC, Stadtmauer EA, Sullivan KM; ZOE-HSCT Study Group Collaborators. Bastidas A, et al. JAMA. 2019 Jul 9;322(2):123-133. doi: 10.1001/jama.2019.9053. JAMA. 2019. PMID: 31287523 Free PMC article. Clinical Trial.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
Dagnew AF, Ilhan O, Lee WS, Woszczyk D, Kwak JY, Bowcock S, Sohn SK, Rodriguez Macías G, Chiou TJ, Quiel D, Aoun M, Navarro Matilla MB, de la Serna J, Milliken S, Murphy J, McNeil SA, Salaun B, Di Paolo E, Campora L, López-Fauqued M, El Idrissi M, Schuind A, Heineman TC, Van den Steen P, Oostvogels L; Zoster-039 study group. Dagnew AF, et al. Lancet Infect Dis. 2019 Sep;19(9):988-1000. doi: 10.1016/S1473-3099(19)30163-X. Epub 2019 Aug 6. Lancet Infect Dis. 2019. PMID: 31399377 Clinical Trial.
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients.
Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Estrada AA, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C. Vissers MFJM, et al. Among authors: alonso alonso m. Clin Transl Sci. 2022 Aug;15(8):2010-2023. doi: 10.1111/cts.13317. Epub 2022 Jun 1. Clin Transl Sci. 2022. PMID: 35649245 Free PMC article. Clinical Trial.
Functional neuroimaging in obesity.
Patriarca L, Magerowski G, Alonso-Alonso M. Patriarca L, et al. Among authors: alonso alonso m. Curr Opin Endocrinol Diabetes Obes. 2017 Apr;24(2):154-159. doi: 10.1097/MED.0000000000000324. Curr Opin Endocrinol Diabetes Obes. 2017. PMID: 28099209 Review.
Involvement of Ceramide Metabolism in Cerebral Ischemia.
Ouro A, Correa-Paz C, Maqueda E, Custodia A, Aramburu-Núñez M, Romaus-Sanjurjo D, Posado-Fernández A, Candamo-Lourido M, Alonso-Alonso ML, Hervella P, Iglesias-Rey R, Castillo J, Campos F, Sobrino T. Ouro A, et al. Among authors: alonso alonso ml. Front Mol Biosci. 2022 Apr 20;9:864618. doi: 10.3389/fmolb.2022.864618. eCollection 2022. Front Mol Biosci. 2022. PMID: 35531465 Free PMC article. Review.
NanoString analysis of mycosis fungoides reveals individual molecular identity.
Alonso-Alonso R, Rodríguez M, García-Díaz N, Tomás-Roca L, Borregón J, Cabezuelo-Rodríguez M, Rebollo-González M, Gallego-Manzano L, Cereceda L, Rodriguez-Pinilla SM, Córdoba R, Fernando García J, Torre-Castro J, García-Álvarez CM, Del Mar Onteniente Gomis M, Rivera-Díaz R, Rodriguez-Peralto JL, Vaqué JP, Ortiz-Romero PL, Piris MÁ. Alonso-Alonso R, et al. Br J Dermatol. 2023 May 24;188(6):812-814. doi: 10.1093/bjd/ljad061. Br J Dermatol. 2023. PMID: 36881924 No abstract available.
Functional neuroimaging in obesity.
Patriarca L, Magerowski G, Alonso-Alonso M. Patriarca L, et al. Among authors: alonso alonso m. Curr Opin Endocrinol Diabetes Obes. 2017 Jun;24(3):260-265. doi: 10.1097/MED.0000000000000340. Curr Opin Endocrinol Diabetes Obes. 2017. PMID: 28277342 Review.
An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy.
Querol L, Lewis RA, Hartung HP, Van Doorn PA, Wallstroem E, Luo X, Alonso-Alonso M, Atassi N, Hughes RAC. Querol L, et al. Among authors: alonso alonso m. J Peripher Nerv Syst. 2023 Jun;28(2):276-285. doi: 10.1111/jns.12551. Epub 2023 May 31. J Peripher Nerv Syst. 2023. PMID: 37119056 Clinical Trial.
180 results